OncoHost

What an incredible experience at in Budapest!

It was a privilege for our CTO, Dr. Yehonatan Elon, to join leading researchers, clinicians, and innovators from around the world to discuss how plasma proteomics and AI are transforming the future of precision oncology.

Thank you to everyone who attended the session, shared insights, and contributed to the meaningful conversations throughout the conference. The engagement and enthusiasm around the potential of data-driven cancer care were truly inspiring 💡

A special thank you to Illumina and SomaLogic for making this opportunity possible and for their continued commitment to advancing cancer research through innovation. 🙏

How can plasma proteomics and AI help redefine precision oncology research?

Join our CTO, Dr. Yehonatan Elon, at European Association for Cancer Research (EACR)2026in Budapest as he discusses how advanced proteomic profiling combined with artificial intelligence is driving a new era of personalized cancer care.

We're proud to contribute to the conversation alongside leaders in cancer research and innovation, and grateful to Illumina and SomaLogic for supporting this important discussion.@
📍 Budapest, Hungary
📅 8June 2026

We’re excited to connect with you at the upcoming Annual Meeting in Chicago!

📍 Visit Us at Booth #28148
Stop by to meet our leadership team and explore how our proteomics and AI-powered platform is driving the next era of precision oncology.

Our team is gearing up for ASCO 2026!
Stop by our booth #28148 or reach out to [email protected] to set up a meeting!

May is National Cancer Research Month, an initiative led by the American Association for Cancer Research (AACR) to highlight the critical importance of life-saving research for the millions of people worldwide affected by cancer.

🔬 It’s Medical Laboratory Professionals Week!

Here’s to the brilliant minds working behind the scenes to power precision medicine and patient care.
Thank you to our incredible lab professionals - Jim Fuller, Amir Gelman, Michael Hoxie & Macalla Tate! Your dedication to accuracy and excellence is what enables innovation to reach each patient.

Our Chief Commercial Officer, Chris Dingman, took the stage to present our latest poster, highlighting the role of biological aging in predicting outcomes. The work underscores our ongoing commitment to equipping physicians with tools that bring greater clarity to complex clinical choices.

Take a closer look at the science driving the future of personalized cancer care.

Attending AACR?
Don’t miss our poster presentation:
“Proteomic aging biomarkers predict survival in immunotherapy-treated tumors.”

🗓 Monday, April 20, 2026
🕘 9:00 AM – 12:00 PM (PDT)

Stop by to explore how proteomic insights are shaping the future of immunotherapy outcomes.

We're proud to announce the acceptance of our abstract for presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting taking place next week in San Diego!

This research highlights the impact of biological aging as a predictive factor for immunotherapy outcomes across multiple tumor types, including , SCLC, renal cell carcinoma (RCC), and melanoma.

Read our news release here:

PR Newswire: press release distribution, targeting, monitoring and marketing PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.

Our team is heading to this weekend! ✈️🔬

We’re looking forward to connecting with the global oncology community, exchanging insights, and driving the future of precision medicine through innovative biomarker-driven solutions.

See you there!